- Home
- SRXH vs NRXP Comparison
SRXH vs NRXP Comparison
Compare SRXH & NRXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRXH
- NRXP
- Stock Information
- Founded
- SRXH 2013
- NRXP 2015
- Country
- SRXH Canada
- NRXP United States
- Employees
- SRXH N/A
- NRXP N/A
- Industry
- SRXH
- NRXP Biotechnology: Pharmaceutical Preparations
- Sector
- SRXH
- NRXP Health Care
- Exchange
- SRXH NYSE
- NRXP Nasdaq
- Market Cap
- SRXH 7.4M
- NRXP 58.5M
- IPO Year
- SRXH N/A
- NRXP N/A
- Fundamental
- Price
- SRXH $0.43
- NRXP $2.83
- Analyst Decision
- SRXH
- NRXP Strong Buy
- Analyst Count
- SRXH 0
- NRXP 4
- Target Price
- SRXH N/A
- NRXP $28.50
- AVG Volume (30 Days)
- SRXH 609.9K
- NRXP 137.7K
- Earning Date
- SRXH 05-15-2025
- NRXP 08-13-2025
- Dividend Yield
- SRXH N/A
- NRXP N/A
- EPS Growth
- SRXH N/A
- NRXP N/A
- EPS
- SRXH N/A
- NRXP N/A
- Revenue
- SRXH $119,421,918.00
- NRXP N/A
- Revenue This Year
- SRXH $26.28
- NRXP N/A
- Revenue Next Year
- SRXH $25.00
- NRXP $230.95
- P/E Ratio
- SRXH N/A
- NRXP N/A
- Revenue Growth
- SRXH 26.27
- NRXP N/A
- 52 Week Low
- SRXH $0.42
- NRXP $1.10
- 52 Week High
- SRXH $3.73
- NRXP $6.01
- Technical
- Relative Strength Index (RSI)
- SRXH N/A
- NRXP 38.54
- Support Level
- SRXH N/A
- NRXP $2.89
- Resistance Level
- SRXH N/A
- NRXP $3.15
- Average True Range (ATR)
- SRXH 0.00
- NRXP 0.14
- MACD
- SRXH 0.00
- NRXP -0.04
- Stochastic Oscillator
- SRXH 0.00
- NRXP 10.22
About SRXH SRX HEALTH SOLUTIONS INC
SRX HealthSolutions Inc is an integrated, Canadian healthcare service provider operating within the specialty healthcare industry. It has developed a collaborative specialty healthcare network (the SRx Network) that strategically positions SRx to achieve business objectives. The SRx Network is comprised of 29 specialty pharmacies, 40 infusion clinics and injection sites, four clinical trials sites, patient support programs (PSP), an allied health team and nursing services, and a wholly owned Health Canada-accredited pharmaceutical wholesale and distribution facility located in Mississauga, Ontario. The SRx Network extends across all 10 Canadian provinces, making it one of the accessible providers of comprehensive, integrated and customized specialty healthcare services in Canada.
About NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.